Q1 2011

Filed May 13, 2011 · 10-Q · 43 days after period end · 0000950123-11-049998

Q1 2011 · 10-Q

Revenue—

Net Income

-$863.00K

no prior Q1 2010 on file

EPS Diluted

-$0.13

no prior Q1 2010 on file

Operating Income-$3,068,000—

Operating Cash Flow-$3,585,000—

Same quarter

no prior Q1 2010 on file

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

ended Mar 31, 2011 · filed May 13, 2011 · 43 d after period end

Oncotelic Therapeutics, Inc. · CIK 908259 · Engraved from SEC EDGAR